ArticleTrials2021

Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial.

Nils Venhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.